Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-155 vs Nevanac in Post Phacoemulsification Patients
NCT01657266Phase 2Completed
- Sponsor
- Laboratorios Sophia
- Start
- Dec 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bromfenac sodium in post-operative ocular inflammation, sponsored by Laboratorios Sophia. Started Dec 2013; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
post-operative ocular inflammation
Beyond the preview
Go deeper on NCT01657266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01657266.